Cardiac and Immune Cell Function in Preeclampsia
NCT04508582
Cardiovascular Diseases, Cardiovascular Risk Factor
London, United Kingdom
View Trial DetailsNCT Number: NCT00005394
To identify and study a large cohort of glucocorticoid remediable aldosteronism (GRA) patients.
Looking for future studies?
Notify MeUp to 100 year
All sexes
Observational
DESIGN NARRATIVE:
The spectrum of the severity and the natural history of the disorder was characterized. Modifying environmental and genetic factors important in regulation of blood pressure were determined. Also, renal physiology was studied in GRA patients to determine how these patients escaped hypokalemia in spite of mineralocorticoid excess. There were four specific aims including: 1) to determine the natural history and prevalence of GRA in various hypertensive populations, 2) to characterize the magnitude of effect imparted on blood pressure by inheritance of GRA and the sources of variation in phenotype expression of the hypertension, 3) to investigate the renal and hormonal mechanisms regulating potassium conservation and loss in GRA, and 4) to characterize the disequilibrium of GRA with Irish and Scottish descent and specific alleles of the aldosterone synthase gene.
The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
No eligibility criteria
National Heart, Lung, and Blood Institute (NHLBI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04508582
Cardiovascular Diseases, Cardiovascular Risk Factor
London, United Kingdom
View Trial DetailsNCT00005315
Cardiovascular Diseases, Heart Diseases
View Trial DetailsNCT00113074
Cardiovascular Diseases, Heart Diseases
Iowa City, Iowa, United States
View Trial DetailsNCT00006294
Cardiovascular Diseases, Coronary Disease
Lexington, Kentucky, United States
View Trial Details